TELLURIDE, CO - The secret is out. Nathan Fielder and Lance Oppenheim’s previously unannounced documentary on Elizabeth Holmes was unveiled as the surprise screening at this year’s Telluride Film Festival, sending attendees scrambling for seats and sparking immediate buzz across the industry.
The film, which had been shrouded in total secrecy prior to its premiere, emerged as the festival’s hidden gem - a last-minute addition that organizers had teased only as a “mystery event.” For those lucky enough to secure a ticket, the reveal came as a genuine shock: a collaboration between Fielder, the deadpan comedic genius behind Nathan For You and The Rehearsal, and Oppenheim, the documentary filmmaker known for Spermworld and A King in Wilderness. The pairing alone suggested something far from a conventional true-crime retelling.
Holmes, the disgraced founder of blood-testing startup Theranos, is a figure who has already been dissected in podcasts, a bestselling book, and a prestige HBO miniseries. So why another project? The answer, according to early audience reactions, lies less in the facts of the case and more in the method of its telling. Fielder’s signature approach - meticulously constructed scenarios, awkward humor, and a forensic examination of human delusion - appears to have found an unexpectedly perfect subject in Holmes, a woman who convinced the world’s most sophisticated investors that a few drops of blood could detect hundreds of diseases.
Oppenheim, whose work often captures marginalized communities and eccentric subcultures with a mix of empathy and strangeness, brings a visual and tonal sensibility that complements Fielder’s narrative playfulness. The result, per those who emerged from the screening, is less a straightforward indictment of Holmes than a meditation on performance, belief, and the theater of startup culture. Attendees described moments of uncomfortable laughter, suggesting the filmmakers have leaned into the inherent absurdity of a CEO who adopted a deep baritone voice to project authority.
The secrecy was a deliberate choice. Telluride has a long history of surprise screenings, but typically those titles are marquee awards contenders from major studios. This particular move - unveiling an untitled documentary with no prior marketing push - feels more like an art-world stunt, which is precisely in line with Fielder’s career-long obsession with blurring the lines between reality and fabrication.
Neither Fielder nor Oppenheim appeared on stage before the screening, and no formal Q&A followed. Festival programmers remained tight-lipped about how the project came to be, though speculation ran high that the film was still in a rough-cut stage and the Telluride showing was partly a test of audience response. What is clear is that the project exists and is far enough along for a festival premiere, suggesting acquisition talks may already be underway.
For Holmes, whose 11-year prison sentence for defrauding investors began in May 2023, the documentary adds another layer to her already complicated public legacy. She remains a polarizing figure - vilified as a con artist, but also viewed by some as a product of a Silicon Valley culture that rewards confidence over competence. Fielder and Oppenheim’s take, early word suggests, refuses easy moralizing. Instead, it reportedly examines Holmes as a character who wrote herself into a narrative so compelling that she could not escape it, even as reality crumbled around her.
The collaboration itself is noteworthy. Fielder has primarily worked in scripted and semi-scripted television, where his deadpan persona often places him in ethically ambiguous situations. Oppenheim, meanwhile, has built a reputation for documenting people who live on society’s fringes, treating them not as curiosities but as complex protagonists. Their shared interest lies in the gap between how people present themselves and who they actually are - a gap that Holmes embodied perhaps more dramatically than anyone in recent memory.
There is no confirmed title for the project, let alone a release date or distribution plans. But the Telluride screening has effectively put the doc on the radar for every major streamer and specialty distributor, many of whom have already expressed interest in the Theranos saga. HBO’s The Dropout offered a dramatized version from Holmes’ perspective, while ABC News produced a podcast. Fielder and Oppenheim’s project, if early reactions hold, may well be the definitive portrait - not because it has more access or more documents, but because it understands Holmes through the lens of performance, a lens through which both filmmakers have spent years peering.
For now, festival-goers are left to parse what they saw. Some described the film as “haunting,” others as “ruthlessly funny,” and a few simply shook their heads and said they needed time to process. That ambiguity is likely exactly what Fielder and Oppenheim intended. In a cultural moment saturated with true-crime content, they’ve delivered something that refuses neat conclusions, leaving viewers to sit with the uncomfortable realization that Holmes’ greatest talent was not technology - it was the ability to make people believe.
A formal announcement regarding distribution is expected in the coming weeks, though producer reps have not commented. For the moment, the project remains distinct in a crowded field: an understated, possibly unpolished, but undeniably provocative take on one of the most bizarre business scandals of the 21st century. And as the Telluride crowd filed out into the mountain dusk, the question on everyone’s lips was the same - when the rest of the world finally gets to see it, will Holmes’ story ever look the same again?
Source: The Hollywood Reporter